Karin Kleinhans
Inversor de Capital Privado en Merck Research Ventures .
Cargos activos de Karin Kleinhans
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Merck Research Ventures
 Merck Research Ventures Investment ManagersFinance Merck Research Ventures (Merck Research) is a venture capital subsidiary of Merck Research Laboratories Massachusetts LLC founded in 2000. The firm is headquartered in Cambridge, Massachusetts. | Inversor de Capital Privado | 01/01/2002 | - |
| Berlin Institute of Health | Consultor / Asesor | 01/01/2021 | - |
Historial de carrera de Karin Kleinhans
Antiguos cargos conocidos de Karin Kleinhans.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| EQT Partners GmbH | Inversor de Capital Privado | 01/01/2015 | 31/12/2022 |
Cardior Pharmaceuticals GmbH
 Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Director/Miembro de la Junta | 01/01/2017 | 31/12/2022 |
Arcum Therapeutics, Inc.
 Arcum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcum Therapeutics, Inc. develops pharmaceutical drug products. It provides technologies aim at therapeutic intervention of multidrug-resistant bacterial infections. The company was founded by Paul M. Dunman and is headquartered in Pittsford, NY. | Director/Miembro de la Junta | 01/01/2021 | 31/12/2022 |
| LSP Services Deutschland GmbH | Analista de Capital Privado | 01/01/2015 | 02/01/2022 |
T-Knife GmbH
 T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany. | Director/Miembro de la Junta | 01/01/2021 | 31/12/2021 |
Formación de Karin Kleinhans.
| Universität Ulm | Doctorate Degree |
Estadísticas
Internacional
| Alemania | 7 |
| Estados Unidos | 3 |
Operativa
| Director/Board Member | 3 |
| Private Equity Investor | 2 |
| Private Equity Analyst | 1 |
Sectorial
| Finance | 4 |
| Health Technology | 4 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
| LSP Services Deutschland GmbH | Finance |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Health Technology |
| EQT Partners GmbH | Finance |
Merck Research Ventures
Merck Research Ventures Investment ManagersFinance Merck Research Ventures (Merck Research) is a venture capital subsidiary of Merck Research Laboratories Massachusetts LLC founded in 2000. The firm is headquartered in Cambridge, Massachusetts. | Finance |
| Berlin Institute of Health | |
T-Knife GmbH
T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany. | Health Technology |
Arcum Therapeutics, Inc.
Arcum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcum Therapeutics, Inc. develops pharmaceutical drug products. It provides technologies aim at therapeutic intervention of multidrug-resistant bacterial infections. The company was founded by Paul M. Dunman and is headquartered in Pittsford, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Karin Kleinhans
- Experiencia
